Log In
Print
BCIQ
Print
Print this Print this
 

dipyridamole (Aggrenox, Asasantin Retard)

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionModified release aspirin plus dipyridamole
Molecular Target Cyclooxygenases (COX)
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today